Skip to main content
. 2015 Apr 13;10(4):e0122360. doi: 10.1371/journal.pone.0122360

Fig 3. Galectin-3 and its relation with the risk of all-cause rehospitalization expressed as incidence rate ratios.

Fig 3

Gal-3 was modelled linearly with the gradient of risk, and centered at a threshold of risk of 17.8 ng/ml. A) Gal-3 and the risk of all-cause rehospitalization in patients with CA125 >67 U/ml. B) Gal-3 and the risk of all-cause rehospitalization in patients with CA125 ≤67 U/ml. CA125: antigen carbohydrate 125; Gal-3: galectin-3. This differential prognostic effect was also observed when CV readmissions were evaluated as endpoint (Fig 4B).